4Front Ventures Corp. Stock price

Equities

FFNT

CA35086B2075

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 03:59:03 2024-03-27 pm EDT 5-day change 1st Jan Change
0.145 CAD 0.00% Intraday chart for 4Front Ventures Corp. +11.54% +11.54%
Sales 2023 * 126M 171M Sales 2024 * 140M 190M Capitalization 97.54M 133M
Net income 2023 * - Net income 2024 * - EV / Sales 2023 * 0.77 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.7 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees 670
Yield 2023 *
-
Yield 2024 *
-
Free-Float 79.11%
More Fundamentals * Assessed data
Dynamic Chart
1 week+11.54%
Current month+20.83%
1 month+20.83%
3 months+3.57%
6 months-58.57%
Current year+11.54%
More quotes
1 week
0.13
Extreme 0.13
0.16
1 month
0.10
Extreme 0.1
0.16
Current year
0.08
Extreme 0.075
0.18
1 year
0.08
Extreme 0.075
0.40
3 years
0.08
Extreme 0.075
1.74
5 years
0.08
Extreme 0.075
2.52
10 years
0.08
Extreme 0.075
2.52
More quotes
Managers TitleAgeSince
Founder 38 -
Chief Executive Officer 50 14-09-30
Director of Finance/CFO 65 Nov. 30
Members of the board TitleAgeSince
Chairman 51 22-04-11
Corporate Officer/Principal 66 -
Director/Board Member 46 20-11-30
More insiders
Date Price Change Volume
24-03-27 0.145 +7.41% 98,962
24-03-26 0.135 +3.85% 11,507
24-03-25 0.13 -7.14% 5,006
24-03-22 0.14 +3.70% 77,500
24-03-21 0.135 +3.85% 3,716

Delayed Quote Canadian Securities Exchange, March 27, 2024 at 03:59 pm EDT

More quotes
4Front Ventures Corp. is a multi-state cannabis operator and retailer. The Company owns or manages licensed cannabis facilities in state-licensed markets in the United States. It manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Island, Verdure, and the Pure Ratios wellness collection, which is distributed through retail outlets, as well as the Company’s chain of branded dispensaries. The Company's segments include THC Cannabis and CBD Wellness. The THC Cannabis segment is engaged in cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third-party retailers, ancillary services supporting wholesale operations, and retail sales direct to end consumers. It also leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. The Company’s CBD Wellness segment sells non-THC hemp derived products across the United States.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.145 CAD
Average target price
0.2 CAD
Spread / Average Target
+37.93%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock 4Front Ventures Corp. - Canadian Securities Exchange